PACS Group (PACS) Expected to Post Quarterly Earnings on Tuesday

PACS Group (NYSE:PACS) is projected to post its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect the company to announce earnings of $0.5370 per share and revenue of $1.4139 billion for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 11:30 AM ET.

PACS Group (NYSE:PACS) last released its earnings results on Monday, May 11th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.36 billion. On average, analysts expect PACS Group to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

PACS Group Price Performance

NYSE PACS opened at $46.12 on Friday. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.27. PACS Group has a 12 month low of $7.50 and a 12 month high of $48.00. The stock has a market cap of $7.30 billion, a price-to-earnings ratio of 29.56, a PEG ratio of 1.38 and a beta of -0.08. The company’s 50 day moving average is $40.94 and its two-hundred day moving average is $37.64.

Insider Buying and Selling

In related news, Director Mark Hancock sold 4,966 shares of the company’s stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $45.06, for a total transaction of $223,767.96. Following the completion of the transaction, the director owned 53,920,512 shares in the company, valued at approximately $2,429,658,270.72. This represents a 0.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle Renee Lewis sold 4,137 shares of the firm’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $45.04, for a total transaction of $186,330.48. Following the transaction, the chief accounting officer directly owned 355,338 shares of the company’s stock, valued at $16,004,423.52. The trade was a 1.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 796,524 shares of company stock valued at $31,611,396. Insiders own 70.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in PACS. Vanguard Group Inc. grew its position in shares of PACS Group by 2.2% during the third quarter. Vanguard Group Inc. now owns 3,939,725 shares of the company’s stock valued at $54,092,000 after purchasing an additional 85,183 shares in the last quarter. Alyeska Investment Group L.P. lifted its position in shares of PACS Group by 159.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after buying an additional 1,382,984 shares in the last quarter. Balyasny Asset Management L.P. boosted its stake in PACS Group by 67.3% during the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock valued at $18,621,000 after buying an additional 545,348 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in PACS Group by 19.6% during the third quarter. Ameriprise Financial Inc. now owns 1,350,551 shares of the company’s stock valued at $18,543,000 after buying an additional 220,939 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in PACS Group by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 1,020,636 shares of the company’s stock valued at $39,189,000 after buying an additional 24,081 shares in the last quarter.

Wall Street Analysts Forecast Growth

PACS has been the subject of a number of analyst reports. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 14th. Oppenheimer lifted their target price on shares of PACS Group from $42.00 to $48.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of PACS Group from a “buy” rating to a “strong-buy” rating in a report on Monday, June 15th. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, July 8th. Finally, UBS Group raised their price target on PACS Group from $50.00 to $57.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $50.60.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.